LCD / Medical Policies Stakeholder Meetings
Compliance Officer Meetings
Closed to members & invited guests.
State | Date/Time | Location |
---|---|---|
J15 KY/OH |
February 25, 2025 |
Microsoft Teams |
Contractor Advisory Committee (CAC) Meetings
CAC meetings are for the purpose of discussing literature related to proposed Local Coverage Determinations (LCDs) before they're developed.
CAC members serve in an advisory capacity. All meetings are open to the public to attend and observe.
State | Date/Time | Location | Agenda | Documentation |
---|---|---|---|---|
Multi-Jurisdictional Host: Palmetto GBA |
February 3, 2025 |
Microsoft Teams |
Registration: Topic: Peripheral Nerve Blocks and Ablations |
|
Multi-Jurisdictional Host: National Government Services |
October 17, 2024 |
WebEx |
Topic: Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) |
|
Multi-Jurisdictional Host: Palmetto GBA |
July 15, 2024 |
Microsoft Teams |
Topics: MolDX: Biomarker Risk Stratification Testing in DCIS |
See Prior CAC Meetings below.
Open Meetings
Open Meetings are for the purpose of discussing new proposed (draft) LCDs and/or the revised portion of a proposed LCD in the 45-day open comment period. These meetings are not a forum to discuss specific claims, the submission of new drugs or indications, or to market forthcoming drugs or medical devices.
Open to the public.
State | Date/Time | Location | Agenda | Documentation |
---|---|---|---|---|
J15 KY/OH |
February 25, 2025 |
Microsoft Teams |
Topics:
Proposed/Draft LCDs not released to final: |
See Prior Open Meetings below.
Provider Touch Point Meetings
Closed to members & invited guests.
State | Date/Time | Location |
---|---|---|
J15 KY/OH |
February 25, 2025 |
Microsoft Teams |
Prior CAC Meetings
Date | Topic | Details | Documentation |
---|---|---|---|
10.19.2023 |
Botulinum Toxins |
|
|
08.16.2023 |
Cervical Fusion |
|
|
05.25.2023 |
Non-Invasive Technology for Coronary Artery Plaque Analysis |
|
|
04.27.2023 |
Trigger Point Injections |
|
|
02.28.2023 |
RPM and RTM for Non-Implantable Devices |
|
|
01.05.2023 |
Micro-Invasive Glaucoma Surgery (MIGS) |
|
|
11.09.2022 |
PET Scans for Inflammation and Infection |
||
03.10.2022 |
Sacroiliac Joint Injections and Procedures |
||
12.07.2021 |
MolDX: Predictive Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis |
||
10.12.2021 |
MolDX: Molecular Testing for Risk Stratification of Upper Gastrointestinal Cancer |
||
09.29.2021 |
Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD) |
||
05.12.2021 |
Amniotic Product Injections for Musculoskeletal Indications, Non-Wound |
||
03.10.2021 |
Platelet Rich Plasma for Non-Wound Care |
||
02.11.2021 |
Epidural Interventions for Chronic Pain Management |
||
01.11.2021 |
Molecular Diagnostic Testing for Pathogens |
||
11.18.2020 |
Electroretinography |
||
05.28.2020 |
Facet Joint and Medical Nerve Branch Procedures |
||
06.29.2019 |
Pharmacogenomics |
||
03.20.2019 |
Vertebral Augmentation |
Prior Open Meetings
State | Date | Topics | Documentation |
---|---|---|---|
J15 OH |
10.30.2024 |
|
|
J15 KY |
10.29.2024 |
|
|
J15 KY/OH |
06.18.2024 |
|
|
J15 KY/OH |
05.16.2024 |
|
|
J15 KY/OH |
02.13.2024 |
|
|
J15 OH |
11.08.2023 |
|
|
J15 KY |
11.07.2023 |
|
|
J15 KY/OH |
07.11.2023 |
|
|
J15 KY/OH |
06.22.2023 |
|
|
J15 KY/OH |
05.17.2023 |
|
|
J15 KY/OH |
02.21.2023 |
|
|
J15 OH |
10.26.2022 |
|
|
J15 KY |
10.25.2022 |
|
|
J15 KY/OH |
06.21.2022 |
|
|
J15 KY/OH |
02.22.2022 |
|
|
J15 KY/OH |
10.13.2021 |
|
|
J15 KY/OH |
07.13.2021 |
|
|
J15 KY/OH |
02.23.2021 |
|
|
J15 KY/OH |
10.13.2020 |
|
|
J15 KY/OH |
10.13.2020 |
|
|
J15 KY/OH |
10.13.2020 |
|
|
J15 KY/OH |
02.18.2020 |
|
|
J15 OH |
10.30.2019 |
|
|
J15 KY |
10.29.2019 |
|
|
J15 KY/OH |
06.18.2019 |
|
|
J15 KY/OH |
05.07.2019 |
|
|
J15 KY/OH |
02.12.2019 |
|